Home Featured Page 171

Featured

Latest

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

Dylan Beynon – Mindbloom – At Home Ketamine

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access...

Trauma and Vulnerability to Suggestion: Redefining How We Understand Consent

COMPASS Pathways plc to announce fourth quarter and full year 2021...

Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through...

Awakn Files Patent For A New Class Of Entactogen-Like Molecules

Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation

Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism

Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules

atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS)...

1...170171172...292 Page 171 of 292

EDITOR PICKS

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

Dylan Beynon – Mindbloom – At Home Ketamine

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access...

Trauma and Vulnerability to Suggestion: Redefining How We Understand Consent

COMPASS Pathways plc to announce fourth quarter and full year 2021...

Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through...

Awakn Files Patent For A New Class Of Entactogen-Like Molecules

Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation

Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism

Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules

atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS)...

EDITOR PICKS

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY